![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Microbiol. , 05 November 2019
Sec. Antimicrobials, Resistance and Chemotherapy
Volume 10 - 2019 | https://doi.org/10.3389/fmicb.2019.02517
This article is part of the Research Topic New approaches in Tuberculosis Drug Discovery View all 12 articles
This article is a correction to:
A Nanostructured Lipid System to Improve the Oral Bioavailability of Ruthenium(II) Complexes for the Treatment of Infections Caused by Mycobacterium tuberculosis
by da Silva, P. B., de Freitas, E. S., Solcia, M. C., de Souza, P. C., da Silva, M. M., Batista, A. A., et al. (2018). Front. Microbiol. 9:2930. doi: 10.3389/fmicb.2018.02930
In the original article, we neglected to include the funder Grant # 2018/00163-0 São Paulo Research Foundation (FAPESP), to for all authors.
The FUNDING is: “This research was funded by grant #2013/14957-5, grant #2013/09265-7 and grant #2018/00163-0 São Paulo Research Foundation (FAPESP) by the Coordination for the Improvement of Higher Education Personnel (CAPES) together with the Post-Doctoral National Program (PNPD), the Programa de Apoio ao Desenvolvimento Científico (PADC) of School of Pharmaceutical Sciences/UNESP, Brazil and the authors thank UNESP for the data of the dissertation (Freitas, 2015).”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: ruthenium(II) complexes, tuberculosis, nanotechnology, oral bioavailability, ICP-MS
Citation: da Silva PB, de Freitas ES, Solcia MC, de Souza PC, da Silva MM, Batista AA, Eismann CE, Rolisola AMCM, Menegário AA, Cardoso RF, Chorilli M and Pavan FR (2019) Corrigendum: A Nanostructured Lipid System to Improve the Oral Bioavailability of Ruthenium(II) Complexes for the Treatment of Infections Caused by Mycobacterium tuberculosis. Front. Microbiol. 10:2517. doi: 10.3389/fmicb.2019.02517
Received: 17 October 2019; Accepted: 18 October 2019;
Published: 05 November 2019.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2019 da Silva, de Freitas, Solcia, de Souza, da Silva, Batista, Eismann, Rolisola, Menegário, Cardoso, Chorilli and Pavan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Patricia B. da Silva, cGF0cmJlbnRAeWFob28uY29tLmJy; Fernando R. Pavan, ZmVybmFuZG8ucGF2YW5AdW5lc3AuYnI=; cGF2YW51bmVzcEBnbWFpbC5jb20=
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.